Beta Bionics iLet Dexcom G6 Convatec infusion set
The iLet Bionic Pancreas with a Dexcom G6 CGM and Convatec infusion set. [Image courtesy of Convatec/Beta Bionics]

Convatec announced that it partnered with Beta Bionics on the launch of the iLet Bionic Pancreas for automated insulin delivery.

FDA last week cleared the Beta Bionics iLet ACE automated insulin pump and iLet dosing decision software.

Convatec offers design and manufacturing services for infusion set technologies and insertion devices for insulin pump treatment. Beta Bionics’ iLet uses its inset and contact detach infusion sets for subcutaneous insulin administration.

The company’s inset, an all-in-one infusion set with a built-in insertion device, connects to iLet on one end and the infusion site at the other. It features a soft, indwelling cannula. Convatec’s contact detach comes with a thin, stainless steel needle. Both infusion sets use kink-free infusion tubing to ensure uninterrupted insulin infusion. They also feature a skin-friendly adhesive tape to secure the set firmly at the infusion site.

Get the full story at our sister site, Drug Delivery Business News.